The Medmen/Pharmacann acquisition passing DOJ regulatory hurdle is BIG news. Here's why:
- What is the DOJ 2nd Request Process?
- Why this is SO important to US Cannabis stocks?
- Which MSOs will benefit from this announcement?
- What this means going forward for US Weed Stocks?
- Are investors fully appreciating how important this is?
- How is the weed market performing since the August lows?
- Which weed stocks will benefit from this?
- Update on the Origin House trade